PECULIARITIES OF ANTIHYPERTENSIVE THERAPY INDICATED IN THERAPEUTIC AND SURGICAL DEPARTMENTS OF THE UNIVERSITY CLINICAL HOSPITAL

PECULIARITIES OF ANTIHYPERTENSIVE THERAPY INDICATED IN THERAPEUTIC AND SURGICAL DEPARTMENTS OF THE UNIVERSITY CLINICAL HOSPITAL

Treatment of arterial hypertension (AH) despite the large variety of antihypertensive drugs currently remains one of the most urgent problems in modern cardiology. However, the scheme used in clinical practice does not always correspond to existing recommendations, in particular, of the European Soc...

Descrición completa

Detalles Bibliográficos
Main Authors:	N. A. Morina, O. D. Savkova, E. A. Fedorova, I. L. Tsarev, A. B. Frolkova, A. E. Tsygankova, A. A. Sokolova, D. A. Napalkov, V. V. Fomin
Formato:	Artigo
Idioma:	Russian
Publicado:	Remedium Group LLC 2017-11-01
Series:	Медицинский совет
Subjects:	arterial hypertension cardiovascular complications antihypertensive therapy angiotensin converting enzyme inhibitors renin-angiotensin-aldosterone system blockers slow calcium channel blockers
Acceso en liña:	https://www.med-sovet.pro/jour/article/view/2007

Títulos similares

Influence of Antihypertensive Treatment on RAAS Peptides in Newly Diagnosed Hypertensive Patients
por: Annina S. Vischer, et al.
Publicado: (2021-03-01)

Role of antihypertensive medicines in prostate cancer: a systematic review
por: Chinonyerem O. Iheanacho, et al.
Publicado: (2024-04-01)

Blood Pressure Control and Antihypertensive Treatment among Hemodialysis Patients—Retrospective Single Center Experience
por: Piotr Skonieczny, et al.
Publicado: (2021-06-01)

Effect of antihypertensive drugs on breast cancer risk in female hypertensive patients: Evidence from observational studies
por: Yang Zhao, et al.
Publicado: (2018-01-01)

Mechanisms of food protein-derived antihypertensive peptides other than ACE inhibition
por: Chibuike C. Udenigwe, et al.
Publicado: (2014-05-01)

Prescription pattern and effectiveness of antihypertensive drugs in patients with aortic dissection who underwent surgery
por: Kuang-Ming Liao, et al.
Publicado: (2023-11-01)

Renin‐Angiotensin Aldosterone System Inhibitors and COVID‐19: A Systematic Review and Meta‐Analysis Revealing Critical Bias Across a Body of Observational Research
por: Jordan Loader, et al.
Publicado: (2022-06-01)

Controversial Roles of the Renin Angiotensin System and Its Modulators During the COVID-19 Pandemic
por: Simon B. Gressens, et al.
Publicado: (2021-02-01)

Angiotensins and rheumatoid arthritis
por: N. M. Savushkina, et al.
Publicado: (2019-01-01)

Association between types of antihypertensive medication and the risk of atrial fibrillation: a nationwide population study
por: JungMin Choi, et al.
Publicado: (2024-05-01)

Association of Cardiovascular Medications With Adverse Outcomes in a Matched Analysis of a National Cohort of Patients With COVID-19
por: Leonard K. Wang, et al.
Publicado: (2023-06-01)

Prospects of using genetic testing to increase the effectiveness of antihypertensive therapy
por: N. V. Drobotya, et al.
Publicado: (2020-06-01)

Effect of different single and combined antihypertensive drug regimens on the mortality of critical care patients
por: Yipeng Fang, et al.
Publicado: (2024-08-01)

Research Progress on Antihypertensive Effect of Polysaccharide and Its Mechanism
por: Jilong XU, et al.
Publicado: (2023-02-01)

Antihypertensive therapy in patients with arterial hypertension and concomitant diseases in real clinical practice (according to the National Registry of Arterial Hypertension, 2019–2022)
por: Anna V. Aksenova, et al.
Publicado: (2024-10-01)

INACTIVATION OF RENIN-ANGIOTENSIN-ALDOSTERONE SYSTEM. WHICH CLASS OF ANTIHYPERTENSIVE MEDICINE PRODUCTS TO PREFER?
por: S. V. Stolov
Publicado: (2020-12-01)

Effect of antihypertensive treatment on the long-term outcome of patients discharged after acute ischemic stroke
por: Konstantinos Tziomalos, et al.
Publicado: (2017-04-01)

Sartans in the treatment of high-risk hypertension: the abilities of candesartan
por: T E Morozova
Publicado: (2013-06-01)

ACE INHIBITORS AND ANGIOTENSIN II RECEPTOR BLOCKERS IN THE TREATMENT OF CARDIOVASCULAR DISEASE: WHAT TO CHOOSE?
por: K. A. Ghyamdzhyan, et al.
Publicado: (2022-12-01)

The renin–angiotensin–aldosterone-system and right heart failure in congenital heart disease
por: Stine Andersen, et al.
Publicado: (2016-06-01)

Effect of ACEi and ARBs vs Non ACEi/ARBs in Hypertension with Respect to Renal Outcomes in COVID-19 Infection: A Retrospective Cohort Study
por: S Ravitej, et al.
Publicado: (2022-11-01)

Assessment of optimal renin-angiotensin-system inhibition strategy in Asian patients with STEMI after primary myocardial revascularization
por: Hye-Jin Park, et al.
Publicado: (2022-01-01)

Hypertension, medications, and risk of severe COVID‐19: A Massachusetts community‐based observational study
por: Ann Z. Bauer, et al.
Publicado: (2021-01-01)

Initial Antihypertensive Regimens in Newly Treated Patients: Real World Evidence From the OneFlorida+ Clinical Research Network
por: Steven M. Smith, et al.
Publicado: (2023-01-01)

Early Rapid Decline in Kidney Function as a Beneficial Sign After Starting Antihypertensive Medication
por: Joachim Beige
Publicado: (2019-06-01)

The Use of Antihypertensive Drugs as Coadjuvant Therapy in Cancer
por: José A. Carlos-Escalante, et al.
Publicado: (2021-05-01)

Angiotensin receptor blocker telmisartan: efficacy, safety and relevance of clinical application
por: Maksimov M.L., et al.
Publicado: (2017-02-01)

Angiotensin receptor blocker telmisartan: efficacy, safety and relevance of clinical application
por: M L Maksimov, et al.
Publicado: (2017-03-01)

Clinical pharmacogenetics of angiotensin II receptor blockers in Iraq
por: Hany A Al-Hussaniy, et al.
Publicado: (2023-01-01)

A Study of Morphological Changes in Renal Afferent Arterioles Induced by Angiotensin II Type 1 Receptor Blockers in Hypertensive Patients
por: Yohko Nagai, et al.
Publicado: (2020-01-01)

Capacities of laboratory diagnosis in the assessment of the activity of the renin-angiotensin-aldosterone system
por: M L Maksimov
Publicado: (2010-06-01)

The Evolving Role of Calcium Channel Blockers in Hypertension Management: Pharmacological and Clinical Considerations
por: Kamryn E. Jones, et al.
Publicado: (2024-06-01)

Dataset for discovering new hypertension small molecules using machine learning-aided computational fragment-based design
por: Odifentse Mapula-e Lehasa, et al.
Publicado: (2024-08-01)

Resistance to antihypertensive drugs targeting Renin-Angiotensin-Aldosterone-System in cancer patients: a case series
por: Mishita Goel, et al.
Publicado: (2020-08-01)

Renin-angiotensin-aldosterone system in climacteric women with arterial hypertension. Antihypertensive therapy features
por: A. E. Bragina, et al.
Publicado: (2005-12-01)

The complete reversal effect following angiotensin-converting enzyme inhibitors or angiotensin receptor blockers and beta-blockers after the primary diagnosis of dilated cardiomyopathy
por: Tao Liu, et al.
Publicado: (2023-01-01)

Impact of renin-angiotensin system inhibitors on the survival of patients with rectal cancer
por: Marcin Zeman, et al.
Publicado: (2022-07-01)

Impact of Renin‐Angiotensin System Inhibitors on Long‐Term Clinical Outcomes of Patients With Coronary Artery Spasm
por: Byoung Geol Choi, et al.
Publicado: (2016-07-01)

Treatment of hypertension during the COVID-19 pandemic: questions about the blockade of the renin-angiotensin-aldosterone system
por: S. G. Kanorskiy
Publicado: (2021-04-01)

Corrigendum: Prescription pattern and effectiveness of antihypertensive drugs in patients with aortic dissection who underwent surgery
por: Kuang-Ming Liao, et al.
Publicado: (2024-06-01)